The role of basiliximab in the evolving renal transplantation immunosuppression protocol.

Biologics · 2008 · PMC2721359 · PMID 19707352

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significancep = 0.10so close (0.05 < p ≤ 0.1)

The overall incidence of acute rejection was lower in the ATG group (14%) compared with the basiliximab group (29%), but this difference did not reach statistical significance (p = 0.10).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.